Why Graincorp, Imugene, iSelect, and Mayne Pharma shares are racing higher

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and dropped into the red. At the time of writing, the benchmark index is down 0.3% to 7,010.8 points.

Four ASX shares that are not letting that hold them back are listed below. Here’s why they are racing higher:

Graincorp Ltd (ASX: GNC)

The Graincorp share price is up almost 6% to $8.08. This morning the grain exporter upgraded its earnings guidance for FY 2022. For the 12 months ending 30 September, Graincorp now expects underlying EBITDA to be in the range of $680 million to $730 million (from $590-$670 million) and underlying net profit after tax in the range of $365 million to $400 million (from $310-$370 million).

Imugene Limited (ASX: IMU)

The Imugene share price is up 10% to 29.7 cents. This follows news that the biotech company has dosed the first patient from the third cohort in the Checkvacc study at the City of Hope hospital in the US. The aim of this study is to activate the immune system of cancer patients to treat and eradicate tumours.

iSelect Ltd (ASX: ISU)

The iSelect share price has rocketed 73% higher to 27.75 cents. Investors have been buying this price comparison website operator after it accepted a takeover offer from Innovation Holdings Australia – the owner or rival website https://ift.tt/bGpyok5. The iSelect board is recommending shareholders vote in favour of the 30 cents per share offer at an upcoming scheme meeting.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is up 6% to 36 cents. This morning this pharmaceutical company announced the sale of its Metrics Contract Services business to Catalent for cash consideration of US$475 million (~A$679 million). Allowing for reinvestment needs, the net proceeds from the sale will be used to repay the syndicated debt facility and to return surplus capital to shareholders.

The post Why Graincorp, Imugene, iSelect, and Mayne Pharma shares are racing higher appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of July 7 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Ed1UZMY

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *